Peak Bio- Warrants (05/01/2026) (PKBOW) has a ROE of 30560.43%, above the sector sector average of -5.72%.
Get informed when a big investor buys or sells
+ Follow30560.43%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Peak Bio- Warrants (05/01/2026) posts a ROE of 30560.43%. That is above the sector sector average of -5.72%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
For its sector stocks, a ROE near -5.72% is typical. Peak Bio- Warrants (05/01/2026)'s 30560.43% is higher that level. That is roughly 534159.6% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
Peak Bio- Warrants (05/01/2026)'s ROE moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 30560.43%; use YoY and peer views to separate noise from signal.
Context for PKBOW's ROE usually means three checks: (1) trend versus prior periods, (2) level versus peers (average -5.72%), and (3) consistency with growth and profitability. This page covers the first two; Peak Bio- Warrants (05/01/2026)'s other metric pages and overview cover the third.